- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Generic Pharma
Impax Laboratories Inc+ Add to Watchlist
IPXL:US36.6700 USD 1.0200 2.71%
As of 20:10:00 ET on 01/30/2015.
Company Profile for Impax Laboratories Inc (IPXL)
Impax Laboratories, Inc. develops, manufactures, and markets both proprietary and multi-source pharmaceutical products utilizing its drug delivery technologies. The Company specializes in the development of niche and controlled release generics, as well as the development of branded products.
Impax Laboratories Inc
Key Executives for Impax Laboratories Inc (IPXL)
|George Frederick Wilkinson "Fred"President/CEO||Michael J NestorPres:Impax Pharmaceuticals|
|Bryan M ReasonsSenior VP:Finance/CFO||Mark A SchlossbergSenior VP/Secy/General Counsel|
|Mark DonohueVP:Investor Relations|